BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Operating cash flow 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$29.6MFY2025 · since FY2018: -$8.5M → $29.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.6M | +147.5% |
| FY2024 | -$62.3M | +6.6% |
| FY2023 | -$66.7M | +21.6% |
| FY2022 | -$85.1M | +15.0% |
| FY2021 | -$100.1M | -92.1% |
| FY2020 | -$52.1M | -111.3% |
| FY2019 | -$24.7M | -191.9% |
| FY2018 | -$8.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net incomeBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating incomeBDTX Operating marginBDTX Free cash flowBDTX Capital expendituresBDTX Return on equityBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Total liabilitiesBDTX Shareholders’ equityBDTX overview →